Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCN-amplificationKUSHNER, Brian H; LAQUAGLIA, Michael P; MODAK, Shakeel et al.Medical and pediatric oncology. 2003, Vol 41, Num 1, pp 80-82, issn 0098-1532, 3 p.Article

Tumour lysis syndrome: an unusual presentationCHUBB, E. A; MALONEY, D; FARLEY-HILLS, E et al.Anaesthesia. 2010, Vol 65, Num 10, pp 1031-1033, issn 0003-2409, 3 p.Article

The Tumor Lysis SyndromeHOWARD, Scott C; JONES, Deborah P; PUI, Ching-Hon et al.The New England journal of medicine. 2011, Vol 364, Num 19, pp 1844-1854, issn 0028-4793, 11 p.Article

Tumour lysis syndrome developing during an operationLEE, M. H; CHENG, K. I; JANG, R. C et al.Anaesthesia. 2007, Vol 62, Num 1, pp 85-87, issn 0003-2409, 3 p.Article

Tumor lysis syndromeTIU, Ramon V; MOUNTANTONAKIS, Stavros E; DUNBAR, Andrew J et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 4, pp 397-407, issn 0094-6176, 11 p.Article

Superior Mediastinal Syndrome: Emergency ManagementJAIN, Richa; BANSAL, Deepak; MARWAHA, R. K et al.Indian journal of pediatrics. 2013, Vol 80, Num 1, pp 55-59, issn 0019-5456, 5 p.Article

Acute tumor lysis syndrome in solid tumors: a case report and review of the literatureBAEKSGAARD, L; SØRENSEN, J. B.Cancer chemotherapy and pharmacology. 2003, Vol 51, Num 3, pp 187-192, issn 0344-5704, 6 p.Article

Pathophysiology, clinical consequences, and treatment of tumor Lysis syndromeDAVIDSON, Michael B; THAKKAR, Snehal; HIX, John K et al.The American journal of medicine. 2004, Vol 116, Num 8, pp 546-554, issn 0002-9343, 9 p.Article

Spontaneous self-alkalinization in spontaneous tumor lysis syndromeROY-CHAUDHURY, P.Kidney international. 2006, Vol 70, Num 5, pp 824-824, issn 0085-2538, 1 p.Article

Acute intraoperative tumour lysis syndromeALAM, Fahad; KI JINN CHIN.Canadian journal of anaesthesia. 2010, Vol 57, Num 10, pp 948-949, issn 0832-610X, 2 p.Article

Intravenous Allopurinol in the Prevention and Treatment of Tumor Lysis SyndromeDUTCHER, Janice P.Seminars in oncology. 2001, Vol 28, Num 2, issn 0093-7754, 23 p., SUP5Serial Issue

Complications of Very High Leukocytosis in Pediatric Acute Leukemia Patients Managed Without Rasburicase and LeukopheresisBAKHSHI, Sameer; RAJKUMAR BIKRAMJIT SINGH; MUNOT, Khushboo et al.Indian journal of pediatrics. 2014, Vol 81, Num 8, pp 817-820, issn 0019-5456, 4 p.Article

Clarifying the role of rasburicase in tumor lysis syndromeSOOD, Amy R; BURRY, Lisa D; CHENG, Doret K. E et al.Pharmacotherapy. 2007, Vol 27, Num 1, pp 111-121, issn 0277-0008, 11 p.Article

Fatal peri-operative acute tumour lysis syndrome precipitated by dexamethasoneMCDONNELL, C; BARLOW, R; CAMPISI, P et al.Anaesthesia. 2008, Vol 63, Num 6, pp 652-655, issn 0003-2409, 4 p.Article

Tumour lysis syndrome: new therapeutic strategies and classificationCAIRO, Mitchell S; BISHOP, Michael.British journal of haematology. 2004, Vol 127, Num 1, pp 3-11, issn 0007-1048, 9 p.Article

Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathyOZKAN, A; HAKYEMEZ, B; OZKALEMKAS, F et al.Neuroradiology (Berlin. Print). 2006, Vol 48, Num 12, pp 887-892, issn 0028-3940, 6 p.Article

Optimal Treatment of Malignancies Associated With HyperuricemiaPUI, Ching-Hon.Seminars in hematology. 2001, Vol 38, Num 4, issn 0037-1963, 39 p., SUP10Conference Proceedings

Actualités sur le traitement du syndrome de lyse tumorale Place de la rasburicase (Fasturtec®)URBIETA, M.Archives de pédiatrie (Paris). 2005, Vol 12, pp 8-12, issn 0929-693X, 5 p., HS1Article

Spontaneous acute tumor lysis syndrome in a DBA/1J mouse: A case report and reviewLOVELACE, Karen; VANGESSEL, Yvonne; ASHER, Ludmila V et al.Toxicologic pathology. 2003, Vol 31, Num 5, pp 486-490, issn 0192-6233, 5 p.Article

Tumor lysis syndrome associated with carboplatin and paclitaxel in a woman with recurrent endometrial cancerGODOY, Heidi; KESTERSON, Joshua P; LELE, Shashikant et al.International journal of gynaecology and obstetrics. 2010, Vol 109, Num 3, issn 0020-7292, p. 254Article

Tumor lysis syndrome soon after treatment with hydroxyurea followed by nilotinib in two patients with chronic-phase chronic myelogenous leukemiaJIAN HUA; IWAKI, Yasunobu; INOUE, Morihiro et al.International journal of hematology. 2013, Vol 98, Num 2, pp 243-246, issn 0925-5710, 4 p.Article

Role of i.v. allopurinol and rasburicase in tumor lysis syndromeHOLDSWORTH, Mark T; NGUYEN, Phuongthao.American journal of health-system pharmacy. 2003, Vol 60, Num 21, pp 2213-2222, issn 1079-2082, 10 p.Article

Tumor Lysis Syndrome and Acute Kidney Injury: Evaluation, Prevention, and ManagementABU-ALFA, Ali K; YOUNES, Anas.American journal of kidney diseases. 2010, Vol 55, Num 5, issn 0272-6386, S1-S13, SUP3Article

Tumor lysis syndrome as a risk factor for posterior reversible encephalopathy syndrome in children with hematological malignanciesSUZUKI, Daisuke; KOBAYASHI, Ryoji; IGUCHI, Akihiro et al.International journal of hematology. 2014, Vol 100, Num 5, pp 485-489, issn 0925-5710, 5 p.Article

A study of rasburicase for the management of hyperuricemia in pediatric patients with newly diagnosed hematologic malignancies at high risk for tumor lysis syndromeKIKUCHI, Akira; KIGASAWA, Hisato; TSUKIMOTO, Ichiro et al.International journal of hematology. 2009, Vol 90, Num 4, pp 492-500, issn 0925-5710, 9 p.Article